Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01220037
Other study ID # MEC 09-3-080
Secondary ID
Status Completed
Phase N/A
First received October 7, 2010
Last updated October 25, 2013
Start date April 2010
Est. completion date December 2011

Study information

Verified date October 2013
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

In the present study, the effects of age and dietary intake will be assessed on myocellular characteristics during 72 hours after a resistance type exercise session.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2011
Est. primary completion date September 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- healthy men between the ages of 18-30 or 70-85 years

Exclusion Criteria:

- Subjects with a recent history or current state of cardiovascular disease, COPD, Parkinson, rheumatoid arthritis, musculoskeletal/orthopaedic disorders, renal disorder, cognitive impairment.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Behavioral:
Adhere to a specific standardized diet for 4 days
24 h before the start of the intervention all subjects will adhere to a standardized diet for 4 days. Young subjects are randomly allocated to either a low protein diet, regular protein diet or high protein diet group. All elderly subjects will adhere to a regular protein diet comparable to the regular protein diet of the young subjects.

Locations

Country Name City State
Netherlands Maastricht University Medical Centre Maastricht Zuid Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle fiber myonuclear and stem cell content baseline No
Primary Muscle fiber myonuclear and stem cell content 12 hours after a single bout of resistance type exercise No
Primary Muscle fiber myonuclear and stem cell content 24 hours after a single bout of resistance type exercise No
Primary Muscle fiber myonuclear and stem cell content 48 hours after a single bout of resistance type exercise No
Primary Muscle fiber myonuclear and stem cell content 72 hours after a single bout resistance type exercise No